CGRRF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.155000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.932600E-01
Normal-vs-Stage2
7.746400E-01
Normal-vs-Stage3
4.508600E-01
Normal-vs-Stage4
8.020400E-01
Stage1-vs-Stage2
3.752600E-01
Stage1-vs-Stage3
3.488200E-01
Stage1-vs-Stage4
6.073400E-01
Stage2-vs-Stage3
4.913400E-01
Stage2-vs-Stage4
5.291000E-01
Stage3-vs-Stage4
3.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.872200E-01
Normal-vs-AfricanAmerican
9.064800E-01
Normal-vs-Asian
3.393800E-01
Caucasian-vs-AfricanAmerican
7.492800E-01
Caucasian-vs-Asian
3.826400E-02
AfricanAmerican-vs-Asian
3.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.551800E-01
Normal-vs-Female
8.654600E-01
Male-vs-Female
6.837000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.656000E-01
Normal-vs-Age(41-60Yrs)
6.585200E-01
Normal-vs-Age(61-80Yrs)
9.213400E-01
Normal-vs-Age(81-100Yrs)
1.858610E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.416800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.439200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.942400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.170400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.858400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.636440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.938400E-01
Normal-vs-Daily Drinker
9.294000E-01
Normal-vs-Weekly Drinker
4.562000E-01
Normal-vs-Occasional Drinker
4.583000E-01
Normal-vs-Social Drinker
7.835600E-01
Non Drinker-vs-Daily Drinker
2.009200E-01
Non Drinker-vs-Weekly Drinker
8.570200E-01
Non Drinker-vs-Occasional Drinker
1.832260E-02
Non Drinker-vs-Social Drinker
2.453200E-01
Daily Drinker-vs-Weekly Drinker
2.859600E-01
Daily Drinker-vs-Occasional Drinker
7.947600E-02
Daily Drinker-vs-Social Drinker
5.006400E-01
Weekly Drinker-vs-Occasional Drinker
2.065700E-02
Weekly Drinker-vs-Social Drinker
2.372600E-01
Occasional Drinker-vs-Social Drinker
5.187800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.250600E-01
Normal-vs-Grade 2
6.015900E-02
Normal-vs-Grade 3
3.459800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.090360E-01
Grade 1-vs-Grade 3
6.654200E-02
Grade 1-vs-Grade 4
3.250600E-01
Grade 2-vs-Grade 3
3.182000E-01
Grade 2-vs-Grade 4
6.015900E-02
Grade 3-vs-Grade 4
3.459800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.152400E-01
Normal-vs-NonDiabetic
8.773800E-01
Diabetic-vs-NonDiabetic
3.696800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.373200E-01
Normal-vs-NoPancreatitis
8.717200E-01
Pancreatitis-vs-NoPancreatitis
1.060450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.840000E-01
Normal-vs-N1
8.200000E-01
N0-vs-N1
1.545180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.150800E-01
Normal-vs-TP53-NonMutant
2.306200E-01
TP53-Mutant-vs-TP53-NonMutant
6.351600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
